PennsylvaniaSB 1902025-2026 Regular SessionSenate

An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review . . . Fund; and imposing a penalty.

Sponsored By: Sharif Street (Democratic)

In Committee

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Sharif Street

    Democratic • Senate

Cosponsors

  • Daniel Laughlin

    Republican • Senate

  • Jay Costa

    Democratic • Senate

  • John I. Kane

    Democratic • Senate

  • Judith L. Schwank

    Democratic • Senate

  • Maria Collett

    Democratic • Senate

  • Timothy P. Kearney

    Democratic • Senate

  • Vincent J. Hughes

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to Banking & Insurance

    1/29/2025Senate

Bill Text

Related Bills

Back to State Legislation